Smartphone monitoring halves avoidable cirrhosis readmissions in randomized trial
-
June 17
Digital tool paired with caregiver engagement lowered 30-day rehospitalizations among patients with cirrhosis in a multicenter trial.
Browse By
Biliary Tract
Colon
Esophagus
Liver
Pancreas
Small Bowel
Stomach
The GI hospitalist: A practice-changing health care opportunity
-
April 23
-
by Vasili Kalas, MD, PhD
The model is reshaping inpatient care, despite slow national adoption.
Pancreatic cystic lesions: A case-based approach
-
April 17
-
by Ross C.D. Buerlein, MD , Himesh B. Zaver, MD , Vanessa M. Shami, MD
Dr. Vanessa Shami, along with Drs. Ross Buerlein and Himesh Zaver, describe characteristic cyst findings on cross-sectional and endoscopic sonographic imaging, fluid analysis results, and management.
Navigating primary sclerosing cholangitis: Diagnosis and the 5 pillars of management
-
February 1
-
by Judy A. Trieu, MD, MPH, Mahesh Krishna, MD, David N. Assis, MD
Primary sclerosing cholangitis remains a challenging disease to diagnose and manage, due to varying presentations, associated disease processes, and lack of targeted treatment.
The Latest
Smartphone monitoring halves avoidable cirrhosis readmissions in randomized trial
-
by Doug Brunk
Digital tool paired with caregiver engagement lowered 30-day rehospitalizations among patients with cirrhosis in a multicenter trial.
ARTE score predicts hepatic decompensation in unresectable hepatocellular carcinoma
-
by Julie Greenbaum
Three routinely available baseline variables identified patients at increased risk for liver decompensation during first-line atezolizumab plus bevacizumab therapy.
Upadacitinib linked to clinical and MRI gains in perianal Crohn's disease
-
by Olivia Anderson
First multicenter real-world cohort to report pelvic MRI outcomes finds earlier treatment works better.
Adding upadacitinib to vedolizumab may double endoscopic remission rates in UC
-
by Jess Allerton
Combination induction for eight weeks outperformed vedolizumab alone in a multicenter randomized trial.
Bringing connected data to enteral feeding
-
by Bob Alaburda
After FDA clearance and an AGA Incubator win, Luminoah's Neal Piper on closing the visibility gap between tube-feeding appointments.
